Those aiming for above-average market returns often engage in the meticulous process of stock picking. Choosing the right stocks can make a substantial difference in your wealth.
As of close of business last night, Core Scientific Inc’s stock clocked out at $19.94, up 5.28% from its previous closing price of $18.94. In other words, the price has increased by $5.28 from its previous closing price. On the day, 18.55 million shares were traded. CORZ stock price reached its highest trading level at $20.17 during the session, while it also had its lowest trading level at $19.25.
Ratios:
To gain a deeper understanding of CORZ’s stock, we examine its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 1.78 and its Current Ratio is at 1.78.
On July 22, 2025, Arete started tracking the stock assigning a Buy rating and target price of $20.
On May 22, 2025, Citizens JMP started tracking the stock assigning a Mkt Outperform rating and target price of $15.Citizens JMP initiated its Mkt Outperform rating on May 22, 2025, with a $15 target price.
Insider Transactions:
Investing in insider trades can also provide an investor with insight into how management views future stock prices. A recent insider transaction in this stock occurred on Jun 25 ’25 when DUCHENE TODD M sold 7,759 shares for $12.39 per share. The transaction valued at 96,142 led to the insider holds 2,049,689 shares of the business.
DUCHENE TODD M bought 7,759 shares of CORZ for $96,142 on Jun 25 ’25. On Jun 06 ’25, another insider, Becker Todd A, who serves as the Former Director of the company, bought 195,687 shares for $12.28 each.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, CORZ now has a Market Capitalization of 6128663040 and an Enterprise Value of 6670959104. For the stock, the TTM Price-to-Sale (P/S) ratio is 17.59. Its current Enterprise Value per Revenue stands at 19.146 whereas that against EBITDA is -122.201.
Stock Price History:
The Beta on a monthly basis for CORZ is 6.52, which has changed by 0.45580328 over the last 52 weeks, in comparison to a change of 0.14201736 over the same period for the S&P500. Over the past 52 weeks, CORZ has reached a high of $19.40, while it has fallen to a 52-week low of $6.20. The 50-Day Moving Average of the stock is 26.32%, while the 200-Day Moving Average is calculated to be 60.48%.
Shares Statistics:
It appears that CORZ traded 15.07M shares on average per day over the past three months and 17006870 shares per day over the past ten days. A total of 303.15M shares are outstanding, with a floating share count of 286.83M. Insiders hold about 6.68% of the company’s shares, while institutions hold 90.48% stake in the company. Shares short for CORZ as of 1759190400 were 62392963 with a Short Ratio of 4.14, compared to 1756425600 on 56587006. Therefore, it implies a Short% of Shares Outstanding of 62392963 and a Short% of Float of 20.49.
Earnings Estimates
At present, 1.0 analysts are actively evaluating the performance of Core Scientific Inc (CORZ) in the stock market.The consensus estimate for the next quarter is $0.09, with high estimates of $0.09 and low estimates of $0.09.
Analysts are recommending an EPS of between $0.31 and $0.31 for the fiscal current year, implying an average EPS of $0.31. EPS for the following year is $1.76, with 1.0 analysts recommending between $1.76 and $1.76.
Revenue Estimates
In. The current quarter, 9 analysts expect revenue to total $123.98M. It ranges from a high estimate of $148.48M to a low estimate of $106M. As of. The current estimate, Core Scientific Inc’s year-ago sales were $95.35MFor the next quarter, 9 analysts are estimating revenue of $160.3M. There is a high estimate of $179.06M for the next quarter, whereas the lowest estimate is $144.3M.
A total of 11 analysts have provided revenue estimates for CORZ’s current fiscal year. The highest revenue estimate was $477.59M, while the lowest revenue estimate was $409M, resulting in an average revenue estimate of $440.79M. In the same quarter a year ago, actual revenue was $510.67MBased on 17 analysts’ estimates, the company’s revenue will be $884.81M in the next fiscal year. The high estimate is $1.16B and the low estimate is $515.5M.
